Search

everythinglearnresearchcommunity

for

Search:↓

Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.

Frontal fibrosing alopecia causes hair loss along the frontal hairline, mainly in postmenopausal women, and needs better treatments.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

A 62-year-old woman with hair loss and skin condition had successful hair transplant surgery lasting 6 years, and medications helped reduce hair fall and promote growth.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Frontal fibrosing alopecia is a type of hair loss that usually happens after menopause.

A genetic marker linked to a type of hair loss was found in most patients studied.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

New grading scale accurately measures hair loss severity and treatment effectiveness.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Many women's hair loss is due to health issues, medication, nutrition, or stress.

Thicker scalp fat may link hair loss with metabolic syndrome.

Topical minoxidil 5% is better for treating female pattern hair loss than topical sildenafil 1%.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Lack of small, fine hair on the front hairline is a key sign of frontal fibrosing alopecia.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

LED therapy can safely and effectively regrow eyebrows in people with frontal fibrosing alopecia.